Trial finder
Find a metronomic therapy clinical trial
316 trials tracked from ClinicalTrials.gov. 65 are recruiting or about to start.
Compiled automatically by Metronomic.com from PubMed and ClinicalTrials.gov. Automated listing. Each item links to its original source. Last refresh: Nov 15, 2026
A listed trial is not a recommendation, and each trial has its own eligibility rules. Your oncologist can tell you whether a trial fits your situation. Not medical advice.
316 trials shown
| Trial | Status | Phase | Conditions | Countries | Last update |
|---|---|---|---|---|---|
| Study of a Propranolol (HEMANGIOL®) and Oral Metronomic Vinorelbine (NAVELBINE®) Combination for Children and Teenagers With Refractory/Relapsing Solid TumorsNCT02897986 · Assistance Publique Hopitaux De Marseille | Recruiting | Phase 1 | Pediatric Cancer | France | 2026-11-12 |
| Axitinib and Oral Metronomic Etoposide for Pediatric Children and AYA Refractory/Relapsing Medulloblastoma and EpendymomaNCT06485908 · Assistance Publique Hopitaux De Marseille | Recruiting | Phase 1, Phase 2 | Medulloblastoma, Ependymoma | France | 2026-11-12 |
| Neoadjuvant of Sintilimab Combined Weekly Metronomic Chemotherapy (POLF) for Resectable Locally Advanced Gastric CancerNCT06054906 · Huashan Hospital | Recruiting | Phase 2 | Gastric Cancer | China | 2026-11-10 |
| Regorafenib in Combination With Multimodal Metronomic Chemotherapy for Chemo-resistant Metastatic Colorectal CancersNCT06425133 · Centre Hospitalier Universitaire de Besancon | Recruiting | Phase 2 | Metastatic Colorectal Cancer | France | 2026-11-04 |
| Pilot Study of IT Topotecan and Maintenance Chemotherapy for HR-EBTs in Children < 6 Years, Post ConsolidationNCT06942039 · C17 Council | Recruiting | Early phase 1 | CNS Embryonal Tumor, CNS, Medulloblastoma, Atypical Teratoid Rhabdoid Tumor, and 11 more | Canada | 2026-11-02 |
| Chemo-immunotherapy Using Ibrutinib Plus Indoximod for Patients With Pediatric Brain CancerNCT05106296 · Theodore S. Johnson | Recruiting | Phase 1 | Ependymoma, Medulloblastoma, Glioblastoma, and 1 more | United States | 2026-11-02 |
| Antiangiogenic Therapy for Children With Recurrent Medulloblastoma, Ependymoma, ATRT and Rare CNS TumorsNCT01356290 · Medical University of Vienna | Recruiting | Phase 2 | Medulloblastoma Recurrent, Ependymoma Recurrent, ATRT Recurrent, and 1 more | Austria, Czechia, Denmark, and 5 more | 2026-10-13 |
| Methotrexate, Erlotinib, and Celecoxib for the Treatment of Recurrent/Metastatic Head and Neck Cancer in a Rural Midwest United States PopulationNCT06997068 · Mayo Clinic | Recruiting | Phase 2 | Metastatic Oral Cavity Carcinoma, Recurrent Oral Cavity Carcinoma, Stage IVC Lip and Oral Cavity Cancer AJCC v8, and 15 more | United States | 2026-10-01 |
| Capecitabine in Low Risk Triple Negative Breast CancerNCT06787339 · Fudan University | Recruiting | Phase 2 | Breast Cancer | China | 2026-09-28 |
| Metronomic Decitabine-Cedazuridine and Venetoclax in R/R AML, HR-MDS, HR/AP MPNNCT07710534 · Virginia Commonwealth University | Recruiting | Phase 2 | Relapsed / Refractory AML, High Risk Myelodysplastic Syndrome, High Risk Myeloproliferative Neoplasms | United States | 2026-09-21 |
| Combination of Tarlatamab and Temozolomide in Patients With Central Nervous System TumorsNCT07243470 · Centre Leon Berard | Recruiting | Phase 1, Phase 2 | Glioma, CNS Tumor, Adult, CNS Tumor, Childhood | France | 2026-09-14 |
| A Study of Temodar With Abexinostat (PCI-24781) for Patients With Recurrent GliomaNCT05698524 · University of Nebraska | Recruiting | Phase 1 | Recurrent High Grade Glioma, Anaplastic Astrocytoma, Anaplastic Oligodendroglioma, and 2 more | United States | 2026-09-14 |
| Prostate Cryoablation Combined With Metronomic Cyclophosphamide for Metastatic Prostate CancerNCT06854250 · Sun Yat-sen University | Recruiting | Phase 2 | Metastatic Prostate Cancer | China | 2026-08-28 |
| Capecitabine in ER+/HER2-negative Breast CancerNCT07631052 · University Health Network, Toronto | Recruiting | Phase 2 | ER-positive, HER2-negative Breast Cancer, Breast Cancer Stage I, Breast Cancer Stage II, and 1 more | Canada | 2026-08-18 |
| Study of Letrozole in Recurrent GliomasNCT03122197 · University of Cincinnati | Recruiting | Early phase 1 | Brain Tumor | United States | 2026-08-18 |
| Metronomic Oral Paclitaxel Monotherapy for Advanced HER2-Negative Breast Cancer: A Two-Stage Dose-Finding and Expansion StudyNCT07602907 · Zhejiang Cancer Hospital | Recruiting | Phase 2 | Advanced Breast Cancer, HER2-negative Breast Cancer | China | 2026-08-11 |
| Metronomic Oral Paclitaxel Plus PD-1/ PD-L1 Inhibitor Maintenance in Advanced Lung Cancer (PULSE Study)NCT07744698 · Anhui Provincial Cancer Hospital | Recruiting | Phase 4 | Squamous Non-Small Cell Lung Cancer sqNSCLC, Extensive-stage Small Cell Lung Cancer (ES-SCLC) | China | 2026-08-04 |
| European Proof-of-Concept Therapeutic Stratification Trial of Molecular Anomalies in Relapsed or Refractory TumorsNCT02813135 · Gustave Roussy, Cancer Campus, Grand Paris | Recruiting | Phase 1, Phase 2 | Pediatric Cancer | Denmark, France, Italy, and 3 more | 2026-07-10 |
| Metronomic Gemcitabine, Mitomycin C, and Thalidomide for Advanced Solid TumorsNCT07671534 · Sarcoma Oncology Research Center, LLC | Recruiting | Phase 2 | Solid Tumor Cancer | United States | 2026-06-26 |
| Metronomic Capecitabine, Oxaliplatin and UGT1A1 Genotype-directed Irinotecan in Metastatic Pancreatic Cancer PatientsNCT05929885 · National Cancer Centre, Singapore | Recruiting | Phase 2 | Metastatic Pancreatic Cancer | Singapore | 2026-06-23 |
| Evaluating the Efficacy and Safety of PD-L1 Monoclonal Antibody Combined With VEX Metronomic Chemotherapy and Concurrent or Delayed Radiotherapy in Patients With Advanced HER2-Negative Breast Cancer With Brain MetastasisNCT06839560 · Cancer Institute and Hospital, Chinese Academy of Medical Sciences | Recruiting | Phase 2 | Brain Metastasis From Advanced HER2-negative Breast Cancer | China | 2026-06-10 |
| Phase II Clinical Trial of PD-L1 in Combination With Vinorelbine + Cyclophosphamide + Capecitabine (VEX) Metronomic Chemotherapy With or Without Radiotherapy for Advanced Triple-negative Breast Cancer.NCT06771609 · Cancer Institute and Hospital, Chinese Academy of Medical Sciences | Recruiting | Phase 2 | Advanced Triple-negative Breast Cancer | China | 2026-06-10 |
| RAIRI Model-Guided Adjuvant Therapy in Nasopharyngeal CarcinomaNCT07590024 · Cancer Institute and Hospital, Chinese Academy of Medical Sciences | Recruiting | Phase 3 | Nasopharyngeal Carcinoma (NPC) | China | 2026-06-04 |
| Real-World RAIRI-Guided Risk Stratification for Adjuvant Therapy Benefit After Chemoradiotherapy in NPCNCT07618078 · Cancer Institute and Hospital, Chinese Academy of Medical Sciences | Recruiting | Not stated | Nasopharyngeal Carcinoma (NPC) | China | 2026-06-03 |
| Consolidation of Toripalimab and Capecitabine After Chemoradiotherapy in ESCCNCT07177794 · Sun Yat-sen University | Recruiting | Phase 3 | Esophageal Cancer, Chemoradiotherapy | China | 2026-04-21 |
| Tislelizumab and Metronomic Capecitabine as Maintenance in High-risk Locoregionally-advanced Nasopharyngeal CarcinomaNCT06093061 · National Cancer Centre, Singapore | Recruiting | Phase 2 | Nasopharyngeal Carcinoma | Singapore | 2026-04-14 |
| Oral Pooled Fecal Microbiotherapy (MaaT033) Concomitant to Cemiplimab Versus Best Investigator's Choice in Patients With Resistance to Treatment Due to Antibiotics Uptake With Advanced Non-small Cell Lung CancerNCT07001618 · Gustave Roussy, Cancer Campus, Grand Paris | Recruiting | Phase 2 | NSCLC (Advanced Non-small Cell Lung Cancer) | France | 2026-04-03 |
| Metronomic Chemotherapy in Wilms Tumor (MetroWilms-1906)NCT05384821 · Centre Oscar Lambret | Recruiting | Phase 1, Phase 2 | Wilms Tumor | France | 2026-03-18 |
| Dalpiciclib Combined With Endocrine Therapy and Metronomic Capecitabine vs Dalpiciclib Combined With Endocrine Therapy for First-line TreatmentNCT07467330 · Fujian Cancer Hospital | Recruiting | Phase 3 | Breast Cancer | China | 2026-03-12 |
| Metronomic Cyclophosphamide With Pembrolizumab in Checkpoint Inhibitor Refractory MelanomaNCT06771544 · University of California, Irvine | Recruiting | Phase 2 | Melanoma, Melanoma Stage III, Melanoma (Skin), and 1 more | United States | 2026-03-10 |
| Reduced-dose Radiotherapy for Stage III Nasopharyngeal Carcinoma Based on the Treatment ResponseNCT06239727 · Sun Yat-sen University | Recruiting | Phase 3 | Nasopharyngeal Carcinoma | China | 2026-03-06 |
| Sirolimus in Combination With Metronomic Chemotherapy in Children With High-Risk Solid TumorsNCT04469530 · Emory University | Recruiting | Phase 2 | Solid Tumor | United States | 2026-02-27 |
| BRE-08 Phase II Study of CMC Regimen for Early Stage Breast CancerNCT06085742 · University of Illinois Chicago | Recruiting | Phase 2 | Breast Cancer | United States | 2025-12-19 |
| Adaptive Immunotherapy for Nasopharyngeal CarcinomaNCT07154069 · Sun Yat-sen University | Recruiting | Phase 3 | Nasopharyngeal Cancinoma (NPC) | China | 2025-11-25 |
| Investigation Into the Integration of Intracavitary Cryoablation and Immunotherapy in Bladder-Preserving TherapyNCT07204132 · Changhai Hospital | Recruiting | Not applicable | Bladder Cancer | China | 2025-10-02 |
| Efficacy And Safety Of Anti-PD-1/PD-L1 Antibodies In Combination With Bevacizumab And Metronomic Cyclophosphamide In Patients With Non-Small Cell Lung Cancer And Cutaneous Melanoma Previously Treated With Immune Checkpoint BlockadeNCT07130032 · EuroCityClinic LLC | Recruiting | Phase 2 | Metastatic Non-small Cell Lung Cancer (NSCLC), Metastatic Cutaneous Melanoma | Russia | 2025-08-19 |
| Steps Against the Burden of Parkinson's Disease - TelAviv/BolognaNCT07105787 · University of Kiel | Recruiting | Not applicable | Parkinson Disease, Falls | Israel, Italy | 2025-08-06 |
| Steps Against the Burden of Parkinson's Disease - RCT KielNCT07058285 · University of Kiel | Recruiting | Not applicable | Parkinson Disease, Fall | Germany | 2025-07-10 |
| Oral Metronomic Vinorelbine and PD-1 Inhibitors in Elderly Non-small Cell Lung CancerNCT07041320 · Anhui Chest Hospital | Recruiting | Not stated | Lung Cancer (NSCLC), Elderly (People Aged 65 or More) | China | 2025-06-27 |
| AK104 and Low-dose Radiation in Recurrent/Metastatic HNSCC After Failure of First-line Systemic TherapyNCT06494995 · Fudan University | Recruiting | Phase 2 | Head and Neck Squamous Cell Carcinoma | China | 2025-06-04 |
| Metronomic Trabectedin, Gemcitabine, and Dacarbazine for Soft Tissue SarcomaNCT04535271 · Sarcoma Oncology Research Center, LLC | Recruiting | Phase 2 | Leiomyosarcoma | United States | 2025-02-24 |
| Metronomic Neoadjuvant Capecitabine and Cyclophosphamide in HUGE Pseudomyxoma Peritonei PatientsNCT06800391 · Fondazione IRCCS Istituto Nazionale dei Tumori, Milano | Recruiting | Phase 2 | Pseudomyxoma Peritonei | Italy | 2025-01-30 |
| Different Methods of Capecitabine in Patients With Non-PCR After Neoadjuvant Therapy for TNBCNCT06700382 · Shu Wang | Recruiting | Not stated | Triple Negative Breast Cancer | China | 2024-11-25 |
| Pembrolizumab and Oral Metronomic Cyclophosphamide in Patients With Chest Wall Breast CancerNCT03971045 · European Institute of Oncology | Recruiting | Phase 2 | Breast Cancer, Chest Wall Tumor | Italy | 2024-11-19 |
| Metronomic Temozolomide in Unfit NENs Patients Metronomic Temozolomide in Unfit Patients With Advanced Neuroendocrine Neoplasms (NENs): MeTe StudyNCT05554003 · European Institute of Oncology | Recruiting | Phase 2 | Neuroendocrine Tumors, Frailty, Chemotherapy Effect | Italy | 2024-11-18 |
| A New Cardiac Rehabilitation Treatment in the Application of Ischemic Heart DiseaseNCT06681506 · Shanghai 10th People's Hospital | Recruiting | Not applicable | Ischemic Heart Disease, Cardiac Rehabilitation | China | 2024-11-08 |
| Adjuvant Metronomic Capecitabine Plus Endocrine Therapy for HR+/HER2- Primary Breast CancerNCT05063136 · Henan Cancer Hospital | Recruiting | Phase 3 | Breast Cancer | China | 2024-11-04 |
| tReatment Individualisation By EBV stratificatiON in Nasopharyngeal Carcinoma: an Umbrella Platform Study (RIBBON-Umbrella)NCT05517135 · National Cancer Centre, Singapore | Recruiting | Not stated | Nasopharyngeal Carcinoma | Singapore | 2024-09-19 |
| Metronomic Capecitabine in Stage III Gastric CancerNCT06313567 · Fudan University | Recruiting | Phase 3 | Gastric Cancer | China | 2024-07-08 |
| Personalized Rendering of Motor System Functional Plasticity Potential to Improve Glioma Resection and Quality of LifeNCT06381726 · University of Milan | Recruiting | Not applicable | Glioma, Glioma, Malignant | Italy | 2024-04-24 |
| A Prospective Exploratory Clinical Study of Metronomic Capecitabine as Adjuvant Therapy in Locoregionally Advanced Hypopharyngeal CarcinomaNCT05940441 · Eye & ENT Hospital of Fudan University | Recruiting | Not stated | to Explore Whether the Adjuvant Therapy of Metronomic Capecitabine Could Improve the Disease-free Survival of Locoregionally Advanced Hypopharyngeal Carcinoma | China | 2023-07-11 |
| Metronomic Capecitabine With or Without PD-1 Antibody as Adjuvant Therapy in High-risk Nasopharyngeal CarcinomaNCT05342792 · Sun Yat-sen University | Recruiting | Phase 3 | Nasopharyngeal Carcinoma | China | 2022-04-25 |
| A Study of the Addition of Metronomic Capecitabine to Standard Adjuvant Therapy in High Risk HER2+ BC paTientsNCT03561740 · Sun Yat-sen University | Recruiting | Phase 3 | Breast Cancer | China | 2018-07-26 |
| Metronomic Therapy for Pediatric Patients With Solid Tumors at High Risk of RecurrenceNCT02446431 · Miller Children's & Women's Hospital Long Beach | Recruiting | Early phase 1 | Solid Tumor | United States | 2015-05-18 |
| Phase II De-Escalation Study of Metronomic Decitabine/Cedazuridine Plus Venetoclax in AMLNCT07867626 · Rutgers, The State University of New Jersey | Not yet recruiting | Phase 2 | Acute Myeloid Leukaemia (AML) | United States | 2026-10-09 |
| Metronomic Temozolomide With Dexbrompheniramine for Recurrent High-Grade Glioma/GlioblastomaNCT07859059 · University of Nebraska | Not yet recruiting | Phase 1, Phase 2 | High Grade Glioma, Glioblastoma, Gliosarcoma | United States | 2026-10-05 |
| Toripalimab Combined With Beat Chemotherapy in the Treatment of Advanced Back-line Small Cell Lung CancerNCT07698054 · Henan Cancer Hospital | Not yet recruiting | Phase 2 | SCLC, Extensive Stage, Bayesian, Metronomic Chemotherapy | Not listed | 2026-07-13 |
| Neoadjuvant Trastuzumab, Pertuzumab Plus Metronomic Vinorelbine for Elderly HER2-Positive Breast CancerNCT07589972 · Tianjin Medical University Cancer Institute and Hospital | Not yet recruiting | Not applicable | Neoadjuvant Therapy in Elderly HER2-Positive Breast Cancer | Not listed | 2026-05-15 |
| Cyclophosphamide and Etoposide as a Metronomic Therapy in Advanced Head and Neck Squamous Cell CancerNCT07361133 · National Cancer Institute, Egypt | Not yet recruiting | Phase 2 | Squamous Cell Carcinoma, Advanced Head and Neck Cancer | Egypt | 2026-04-16 |
| Benmelstobart in Combination With Anlotinib and Oral Metronomic Cyclophosphamide in the Treatment of Recurrent Epithelial OvariaN, Fallopian Tube, or Primary Peritoneal CancerNCT07489300 · Second Affiliated Hospital, Zhejiang University, School of Medicine | Not yet recruiting | Phase 2 | Ovarian Cancer, Fallopian Tube Cancers, Primary Peritoneal Cancer | Not listed | 2026-03-24 |
| A Single-arm, Prospective, Phase II Clinical Study of the Combination of Entinostat and Oral Paclitaxel in the Treatment of HR+HER2- Advanced Breast CancerNCT07441486 · Tianjin Medical University Cancer Institute and Hospital | Not yet recruiting | Phase 2 | Breast Cancer | Not listed | 2026-03-02 |
| Oral Metronomic Capecitabine Combined With Pyrotinib in ADC-treated HER2-positive Metastatic Breast CancerNCT07019337 · Cancer Institute and Hospital, Chinese Academy of Medical Sciences | Not yet recruiting | Phase 2 | HER2-positive Breast Cancer, Metastatic Breast Cancer | Not listed | 2025-06-13 |
| Metronomic Capecitabine with Camrelizumab and Apatinib Mesylate for Treatment of Advanced Pancreatic CancerNCT06759090 · Zhejiang University | Not yet recruiting | Phase 2 | Metastatic Pancreatic Carcinoma | China | 2025-01-06 |
| Efficacy and Safety of PD-L1 Monoclonal Antibody Combined With Metronomic VEX in Advanced Triple-negative Breast CancerNCT06229067 · Cancer Institute and Hospital, Chinese Academy of Medical Sciences | Not yet recruiting | Phase 2 | Breast Cancer, Triple Negative Breast Cancer | Not listed | 2024-01-29 |
| Utidelone Plus Capecitabine Versus Taxane Plus Capecitabine in HER2-negative Locally Advanced or Metastatic Breast CancerNCT05172518 · Sun Yat-sen University | Not yet recruiting | Phase 3 | Breast Neoplasms, Locally Advanced or Metastatic Breast Cancer | China | 2021-12-29 |
| The Efficacy and Safety of Pyrotinib, Trastuzumab Combined With Taxanes in the Treatment of Trastuzumab-treated HER2+ Advanced Breast Cancer (ABC).NCT06217185 · Hebei Medical University Fourth Hospital | Active, not recruiting | Phase 4 | HER2-positive Breast Cancer, Advanced Breast Cancer | China | 2026-11-10 |
| Regorafenib With Low-dose Chemotherapies and Aspirin Followed by Standard Chemotherapies in Metastatic Colorectal CancerNCT05462613 · Centre Hospitalier Universitaire de Besancon | Active, not recruiting | Phase 2, Phase 3 | Metastatic Colorectal Cancer | France | 2026-11-04 |
| Pediatric Trial of Indoximod With Chemotherapy and Radiation for Relapsed Brain Tumors or Newly Diagnosed DIPGNCT04049669 · Theodore S. Johnson | Active, not recruiting | Phase 2 | Glioblastoma, Medulloblastoma, Ependymoma, and 1 more | United States | 2026-11-02 |
| Allogeneic Tumor Cell Vaccination With Oral Metronomic Cytoxan in Patients With High-Risk NeuroblastomaNCT01192555 · Baylor College of Medicine | Active, not recruiting | Phase 1, Phase 2 | Neuroblastoma | United States | 2026-10-02 |
| Bevacizumab/Doxorubicin/Radiation for SarcomaNCT01746238 · Massachusetts General Hospital | Active, not recruiting | Phase 1 | Sarcoma | United States | 2026-09-08 |
| Toripalimab vs. Placebo Wtih GP Induction Chemotherapy in Locoregionally Advanced Nasopharyngeal CarcinomaNCT06712888 · Sun Yat-sen University | Active, not recruiting | Phase 3 | Nasopharyngeal Carcinoma (NPC) | China | 2026-08-13 |
| Sirolimus in Combination With Metronomic Chemotherapy in Children With Recurrent and/or Refractory Solid and CNS TumorsNCT02574728 · Emory University | Active, not recruiting | Phase 2 | Cancer | United States | 2026-03-02 |
| Concurrent Chemoradiotherapy With or Without Metronomic Capecitabine in High-Risk T1-2N1M0 NPCNCT07248670 · Chongqing University Cancer Hospital | Active, not recruiting | Phase 3 | Nasopharyngeal Cancinoma (NPC) | China | 2025-11-25 |
| Boost GVAX Pancreas Vaccine With or Without CY in Patients With Pancreas CancerNCT01088789 · Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins | Active, not recruiting | Phase 2 | Pancreatic Cancer | United States | 2025-08-26 |
| Cyclophosphamide and Dexamethasone for the Treatment of Metastatic Castration Resistant Prostate CancerNCT05479578 · Rashmi Verma, MD | Active, not recruiting | Phase 1 | Castration-Resistant Prostate Carcinoma, Metastatic Prostate Adenocarcinoma, Stage IVB Prostate Cancer American Joint Committee on Cancer (AJCC) V8 | United States | 2025-01-08 |
| DPX-Survivac and Checkpoint Inhibitor in DLBCLNCT03349450 · Sunnybrook Health Sciences Centre | Completed | Phase 2 | Adult Diffuse Large Cell Lymphoma, Recurrent, Adult Refractory Diffuse Large B-Cell Lymphoma | Canada | 2026-09-25 |
| Metronomic Chemotherapy by Cyclophosphamide Versus Megestrol in Palliative CancerNCT00420563 · Centre Oscar Lambret | Completed | Phase 2 | Cancer | France | 2026-09-17 |
| Imatinib Mesylate And Cyclophosphamide In Metronomic Administration: Dose Escalation Study Of Imatinib MesylateNCT01046487 · Centre Oscar Lambret | Completed | Phase 1 | Cancer | France | 2026-09-17 |
| Trial of a Vaccination With Tumor Antigen-loaded Dendritic Cell-derived ExosomesNCT01159288 · Gustave Roussy, Cancer Campus, Grand Paris | Completed | Phase 2 | Non Small Cell Lung Cancer | France | 2026-08-17 |
| Trial to Evaluate Safety and Efficacy of Vinorelbine With Metronomic Administration in Combination With Atezolizumab as Second-line Treatment for Patients With Stage IV Non-small Cell Lung CancerNCT03801304 · University Hospital, Brest | Completed | Phase 2 | Non-small Cell Lung Cancer | France | 2026-06-30 |
| Safety and Efficacy of Metronomic Cyclophosphamide, Metformin and Olaparib in Endometrial Cancer PatientsNCT02755844 · Hospices Civils de Lyon | Completed | Phase 1, Phase 2 | Recurrent Endometrial Cancer | France | 2026-05-27 |
| Temozolomide + Nivolumab in MGMT Methylated Oesophagogastric CancerNCT04984733 · University of Southampton | Completed | Phase 2 | Adenocarcinoma - GEJ, Cancer of Esophagus | United Kingdom | 2026-05-18 |
| Weekly Paclitaxel and Cyclophosphamide in Metronomic Administration : Dose Escalation Study of Weekly PaclitaxelNCT01374620 · Centre Oscar Lambret | Completed | Phase 1 | Cancer | France | 2026-03-16 |
| Metronomic Capecitabine Plus Aromatase Inhibitor for First Line Treatment in HR(+), Her2(-) Metastatic Breast CancerNCT02767661 · Sun Yat-sen University | Completed | Phase 3 | Breast Cancer | China | 2026-02-27 |
| Targeting Microenvironment and Cellular Immunity in Sarcomas Weekly Trabectedin Combined With Metronomic CyclophosphamideNCT02805725 · Institut Bergonié | Completed | Phase 1, Phase 2 | Soft-tissue Sarcomas | France | 2026-01-14 |
| Combination of MK3475 and Metronomic Cyclophosphamide in Patients With Advanced Sarcomas : Multicentre Phase II TrialNCT02406781 · Institut Bergonié | Completed | Phase 2 | Sarcoma | France | 2025-12-10 |
| Ixazomib, Cyclophosphamide and Dexamethasone for Multiple MyelomaNCT02412228 · John L. Reagan | Completed | Phase 2 | Multiple Myeloma | United States | 2025-10-15 |
| Oral Pazopanib Plus Oral Topotecan Metronomic Antiangiogenic Therapy for Recurrent Glioblastoma Multiforme (A) Without Prior Bevacizumab Exposure and (B) After Failing Prior BevacizumabNCT01931098 · National Cancer Institute (NCI) | Completed | Phase 2 | Glioblastoma, Glioblastoma Multiforme, Gliosarcoma, and 2 more | United States | 2025-08-11 |
| Metronomic Chemotherapy in Patients With Advanced Solid Tumor With Bone Metastasis and Advanced Pretreated OsteosarcomaNCT02517918 · Institut Bergonié | Completed | Phase 1 | Solid Tumor, Osteosarcoma | France | 2025-06-08 |
| A Study of Different Dosing Schedules of Selinexor in Sarcoma PatientsNCT04811196 · University Health Network, Toronto | Completed | Phase 1 | Soft Tissue Sarcoma, Malignant Peripheral Nerve Sheath Tumor (MPNST), Leiomyosarcoma, and 1 more | Canada | 2025-05-29 |
| Metronomic Oral Vinorelbine Plus Anti-PD-L1/Anti-CTLA4 ImmunothErapy in Patients With Advanced Solid TumoursNCT03518606 · UNICANCER | Completed | Phase 1, Phase 2 | Advanced Solid Tumours, Breast Cancer, Head and Neck Cancer, and 2 more | France | 2025-01-15 |
| Peptide Receptor Radionuclide Therapy With 177Lu-Dotatate Associated With Metronomic Capecitabine In Patients Affected By Aggressive Gastro-Etero-Pancreatic Neuroendocrine TumorsNCT02736500 · Istituto Romagnolo per lo Studio dei Tumori Dino Amadori IRST S.r.l. IRCCS | Completed | Phase 1, Phase 2 | Neuroendocrine Tumors, Gastro Entero Pancreatic Neuroendocrine Tumors | Italy | 2025-01-13 |
| Regorafenib in Combination With Metronomic Chemotherapies, and Low-dose Aspirin in Metastatic Colorectal CancerNCT04534218 · Centre Hospitalier Universitaire de Besancon | Completed | Phase 2 | Colo-rectal Cancer, Metastatic Cancer | France | 2024-12-20 |
| Autologous Dendritic Cells, Metronomic Cyclophosphamide and Checkpoint Blockade in Children With Relapsed HGGNCT03879512 · Wuerzburg University Hospital | Completed | Phase 1, Phase 2 | Childhood Glioblastoma | Germany | 2024-09-19 |
| Metronomic Treatment in Children and Adolescents With Recurrent or Progressive High Risk NeuroblastomaNCT02641314 · University of Cologne | Completed | Phase 2 | Recurrent Neuroblastoma | Germany | 2024-05-10 |
| Metronomic Chemotherapy in a Real-world Population of Advanced Breast Cancer PatientsNCT06373744 · Sun Yat-sen University | Completed | Not stated | Breast Cancer | China | 2024-04-18 |
| MEtronomic TrEatment Option in Advanced bReast cAncerNCT02954055 · ETOP IBCSG Partners Foundation | Completed | Phase 2 | Breast Cancer | Italy | 2024-02-26 |
| Study in Letrozole Combined With Metronomic Oral Cyclophosphamide in Elderly Metastasis Breast Cancer PatientsNCT02583828 · Capital Medical University | Completed | Not applicable | Breast Neoplasms, Neoplasm Metastasis | China | 2024-02-07 |
| Anti-Angiogenic Therapy Post Transplant (ASCR) for Pediatric Solid TumorsNCT01661400 · Washington University School of Medicine | Completed | Phase 1 | Glioma, Neuroectodermal Tumors, Primitive, Wilms Tumor, and 4 more | United States | 2024-01-31 |
| Metastatic or Refractory Soft Tissue Sarcomas and Metronomic Cyclophosphamide: Further Assessment of Efficacy and SafetyNCT06216990 · Centre Hospitalier Universitaire de Besancon | Completed | Not stated | Sarcoma, Soft Tissue Sarcoma | Not listed | 2024-01-22 |
| Fruquintinib-based Treatment for Refractory Bone and Soft Tissue Sarcomas After Several Lines of TKIs' ResistanceNCT06202599 · Peking University People's Hospital | Completed | Not stated | Bone Sarcoma, Soft Tissue Sarcoma, Refractory Tumor | China | 2024-01-17 |
| Effect of Low Dose Metronomic Chemotherapy in Metastatic Breast CancerNCT04350021 · Vastra Gotaland Region | Completed | Not stated | Breast Cancer Metastatic, Chemotherapy Effect | Sweden | 2024-01-17 |
| Study of Vinorelbine and Cisplatin as Induction Therapy With Radiotherapy in Patients With Unresectable NSCLCNCT02709720 · Spanish Lung Cancer Group | Completed | Phase 2 | Lung Cancer | Spain | 2024-01-11 |
| Racotumomab in Patients With High-risk NeuroblastomaNCT02998983 · Laboratorio Elea Phoenix S.A. | Completed | Phase 2 | Neuroblastoma | Argentina | 2023-09-11 |
| N2007-02:Bevacizumab,Cyclophosphamide,& Zoledronic Acid in Patients W/ Recurrent or Refractory High-Risk NeuroblastomaNCT00885326 · New Approaches to Neuroblastoma Therapy Consortium | Completed | Phase 1 | Neuroblastoma | Canada, United States | 2023-04-10 |
| A Clinical Trial Using Metronomic Oral Low-dose Cyclophosphamide Alternating With Low-dose Oral Methotrexate With Continuous Celecoxib and Weekly Vinblastine in Children and Adolescents With Relapsed or Progressing soliD Tumours.NCT01285817 · Assistance Publique Hopitaux De Marseille | Completed | Phase 2 | Survival Without Progression | France | 2023-03-13 |
| Dasatinib, Bevacizumab, Paclitaxel in Patients With Advanced MalignanciesNCT01015222 · M.D. Anderson Cancer Center | Completed | Phase 1 | Advanced Cancer | United States | 2022-11-23 |
| Metronomic Chemotherapy Based on Adaptative Bio-mathematical Model of Oral Vinorelbine in Patients With NSCLC or MPMNCT02555007 · Assistance Publique Hopitaux De Marseille | Completed | Phase 1 | Non Small Cell Lung Cancer (NSCLC), Malignant Pleural Mesothelioma (MPM) | France | 2022-11-17 |
| Elderly Metastatic Breast Cancer: Pertuzumab-Herceptin vs Pertuzumab-Herceptin-Metronomic Chemotherapy, Followed by T-DM1NCT01597414 · European Organisation for Research and Treatment of Cancer - EORTC | Completed | Phase 2 | Elderly Metastatic Breast Cancer Population | Belgium, France, Italy, and 5 more | 2022-11-17 |
| Phase I Dose Escalation Study of Topotecan and Pazopanib in Children With Recurrent/Refractory Solid TumoursNCT02303028 · The Hospital for Sick Children | Completed | Phase 1, Phase 2 | Solid Tumors | Canada | 2022-06-28 |
| Metronomic Chemotherapy in Elderly Non-fit Patients With Aggressive B-Cell LymphomasNCT03161054 · Fondazione Italiana Linfomi - ETS | Completed | Phase 2 | Aggressive Non-Hodgkin Lymphoma | Italy | 2021-12-20 |
| Pembrolizumab, Bevacizumab, and Cyclophosphamide in Treating Patients With Recurrent Ovarian, Fallopian Tube, or Primary Peritoneal CancerNCT02853318 · Roswell Park Cancer Institute | Completed | Phase 2 | Fallopian Tube Clear Cell Adenocarcinoma, Fallopian Tube Endometrioid Adenocarcinoma, Fallopian Tube Mucinous Adenocarcinoma, and 11 more | United States | 2021-10-06 |
| A Proof-of-concept Clinical Trial Assessing the Safety of the Coordinated Undermining of Survival Paths by 9 Repurposed Drugs Combined With Metronomic Temozolomide (CUSP9v3 Treatment Protocol) for Recurrent GlioblastomaNCT02770378 · University of Ulm | Completed | Phase 1, Phase 2 | Glioblastoma | Germany | 2021-10-05 |
| Evaluation of Pembrolizumab in Lymphopenic Metastatic Breast Cancer Patients Treated With Metronomic CyclophosphamideNCT03139851 · Centre Leon Berard | Completed | Phase 2 | Metastatic Breast Cancer | France | 2021-09-10 |
| Pharmaco-immunological Study of Interferon-alpha and Metronomic Cyclophosphamide Association in Neuroendocrine TumorsNCT02838342 · Centre Hospitalier Universitaire de Besancon | Completed | Phase 2 | Neuroendocrine Tumors | France | 2021-08-02 |
| OXIRI [Oxaliplatin (O), Xeloda (X) and Irinotecan (I)] in Pancreatic AdenocarcinomaNCT02368860 · National Cancer Centre, Singapore | Completed | Phase 1 | Pancreatic Cancer | Singapore | 2021-06-01 |
| Temozolomide for Second-Line Treatment of Neuroendocrine CarcinomasNCT04122911 · National Cancer Institute, Naples | Completed | Phase 2 | Neuroendocrine Carcinomas | Italy | 2020-10-26 |
| Multimodal Molecular Targeted Therapy to Treat Relapsed or Refractory High-risk NeuroblastomaNCT01467986 · University of Regensburg | Completed | Phase 2 | Neuroblastoma Recurrent | Germany | 2020-10-06 |
| Imatinib, Bevacizumab, and Cyclophosphamide in Patients With Refractory Metastatic Solid TumorsNCT00390156 · University of California, San Francisco | Completed | Phase 1 | Unspecified Adult Solid Tumor | United States | 2020-07-28 |
| Eribulin Mesylate in Treating Patients With Previously Treated Metastatic Breast CancerNCT01908101 · University of Washington | Completed | Phase 2 | Recurrent Breast Carcinoma, Stage IV Breast Cancer | United States | 2020-07-23 |
| Study of Metronomic Capecitabine and Oxaliplatin Versus XELOX in Egyptian Metastatic Colorectal Cancer PatientsNCT04425564 · National Cancer Institute, Egypt | Completed | Phase 2 | Clinical Response, Toxicity, Survival | Not listed | 2020-06-11 |
| Aflac ST0901 CHOANOME - Sirolimus in Solid TumorsNCT01331135 · Emory University | Completed | Phase 1 | Ewing's Sarcoma, Osteosarcoma, Astrocytoma, and 13 more | United States | 2020-05-29 |
| Efficacy of Capecitabine Metronomic Chemotherapy to Triple-negative Breast CancerNCT01112826 · Sun Yat-sen University | Completed | Phase 3 | Breast Cancer | China | 2020-05-27 |
| Protracted Etoposide During Induction Therapy for High Risk NeuroblastomaNCT00578864 · Baylor College of Medicine | Completed | Phase 2 | Neuroblastoma | United States | 2020-03-27 |
| Dose-finding Study of BP-C1 in Patients With Stage IV Breast CancerNCT04298333 · Meabco A/S | Completed | Phase 1 | Metastatic Breast Cancer, Stage IV Breast Cancer | Indonesia, Taiwan, Thailand | 2020-03-06 |
| Vaccine Therapy With or Without Cyclophosphamide in Treating Patients Undergoing Chemotherapy and Radiation Therapy for Stage I or Stage II Pancreatic Cancer That Can Be Removed by SurgeryNCT00727441 · Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins | Completed | Phase 2 | Pancreatic Cancer | United States | 2020-02-25 |
| Low Dose Metronomic Poly-chemotherapy for Metastatic CRCNCT02280694 · HaEmek Medical Center, Israel | Completed | Phase 2 | Colorectal Cancer | Israel | 2020-02-12 |
| Vaccination in Prostate Cancer (VANCE)NCT02390063 · University of Oxford | Completed | Phase 1 | Prostate Cancer | United Kingdom | 2020-02-10 |
| ABT-888 Plus Metronomic Cyclophosphamide to Treat CancerNCT01445522 · National Cancer Institute (NCI) | Completed | Phase 1 | Neoplasms, Lymphoma | United States | 2019-12-17 |
| Phase I Clinical Trial of Cryoimmunotherapy Against Prostate CancerNCT02423928 · Alden Cancer Therapy II | Completed | Phase 1 | Prostate Cancer | Norway | 2019-10-25 |
| Study of 5-fluorouracil (5-FU), Nab®1-paclitaxel, Bevacizumab, Leucovorin, and Oxaliplatin in Patients With Metastatic Pancreatic CancerNCT02620800 · Celgene | Completed | Phase 1 | Metastatic Pancreas Adenocarcinoma | United States | 2019-10-22 |
| BP-C1 in Short-term Treatment of Patients With Metastatic Breast CancerNCT02783794 · Meabco A/S | Completed | Phase 2 | Metastatic Breast Cancer, Stage IV Breast Cancer | Russia, Thailand | 2019-10-10 |
| BP-C1 Monotherapy in Patients With Metastatic Breast Cancer Cancer: Estimation of Optimal Duration of TreatmentNCT03789019 · Meabco A/S | Completed | Phase 2 | Metastatic Breast Cancer, Stage IV Breast Cancer | Russia, Thailand | 2019-10-10 |
| BP-C1 in Short-term Treatment of Thai Patients With Metastatic Breast CancerNCT03603197 · Meabco A/S | Completed | Phase 2 | Metastatic Breast Cancer, Stage IV Breast Cancer | Thailand | 2019-10-07 |
| BP-C1 in Metastatic Breast Cancer PatientsNCT01861509 · Meabco A/S | Completed | Phase 1 | Metastatic Breast Cancer, Stage IV Breast Cancer | Israel, Thailand | 2019-10-07 |
| Cyclophosphamide for Nasopharyngeal CarcinomaNCT02794077 · The University of Hong Kong | Completed | Phase 2 | Recurrent Nasopharyngeal Undifferentiated Carcinoma, Stage IV Nasopharyngeal Undifferentiated Carcinoma | Not listed | 2019-10-02 |
| Potentiation of Cetuximab by Tregs Depletion With CSA in Advanced Head & Neck CancerNCT01581970 · Masonic Cancer Center, University of Minnesota | Completed | Phase 2 | Head and Neck Cancer, Head and Neck Squamous Cell Carcinoma | United States | 2019-09-11 |
| Metronomic Treatment With Daily Oral Vinorelbine as First-line Chemotherapy in Patients With Advanced/Metastatic Hormone Receptor Positive (HR+)/Human Epidermal Growth Factor Receptor 2 Negative (HER2-) Breast CancerNCT03007992 · Johannes Gutenberg University Mainz | Completed | Phase 2 | Metastatic Breast Cancer | Germany | 2019-08-12 |
| Low Dose Cyclophosphamide +/-- Nintedanib in Advanced Ovarian CancerNCT01610869 · University College, London | Completed | Phase 2 | Ovarian Cancer, Fallopian Tube Cancer | United Kingdom | 2019-05-29 |
| Metronomic Low-Dose Cyclophosphamide and Methotrexate With or Without Bevacizumab in Treating Women With Metastatic Breast CancerNCT00083031 · Dana-Farber Cancer Institute | Completed | Phase 2 | Breast Cancer | United States | 2019-05-21 |
| Metronomic Therapy in Metastatic Breast Cancer.NCT01131195 · Swiss Cancer Institute | Completed | Phase 3 | Breast Cancer | Switzerland | 2019-05-15 |
| Maintenance Low Dose Oral Navelbine In Patients With Non Small Cell Lung Cancer - MA.NI.LA TrialNCT02176369 · Fondazione IRCCS Istituto Nazionale dei Tumori, Milano | Completed | Phase 2 | Non-small Cell Lung Cancer Stage IIIB, Non-small Cell Lung Cancer Stage IV | Italy | 2019-04-22 |
| Efficacy Study of Sorafenib and Cyclophosphamide to Treat Neuroendocrine TumorsNCT00605566 · University Health Network, Toronto | Completed | Phase 2 | Neuroendocrine Tumors | Canada | 2019-02-19 |
| BP-C1 in Short-term Treatment of Metastatic Pancreatic CancerNCT03627390 · Meabco A/S | Completed | Phase 2 | Metastatic Pancreatic Cancer, Unresectable Pancreatic Cancer | Egypt | 2018-11-15 |
| Phase 0 Study of Metronomic Oral Vinorelbine and Letrozole in HR+/HER2-negative Early Breast Cancer Patients (VENTANA)NCT02802748 · SOLTI Breast Cancer Research Group | Completed | Early phase 1 | Breast Cancer | Spain | 2018-09-20 |
| Temozolomide & RT Followed by Dose Dense vs Temozolomide & Retinoic Acid in Pts w/GlioblastomaNCT00200161 · Memorial Sloan Kettering Cancer Center | Completed | Phase 2 | Glioblastoma, Gliomas | United States | 2018-03-07 |
| Study of Capecitabine and Cyclophosphamide Administered as a Single Pill in Patients With Advanced Breast CancerNCT02664103 · Sanofi | Completed | Phase 2 | Breast Cancer Metastatic | India | 2018-02-01 |
| Phase 1 Study Testing the Combination of Aflibercept and Capecitabine in Metastatic Digestive and Breast CancersNCT01843725 · Jules Bordet Institute | Completed | Phase 1 | Metastatic Colorectal Cancers, Metastatic Gastric Cancers, Metastatic Oesophageal Cancers, and 3 more | Belgium | 2018-01-31 |
| Maintenance Bevacizumab Only or Bevacizumab Plus Metronomic Chemotherapy in Advanced Colorectal CancerNCT02271464 · Azienda Ospedaliero, Universitaria Pisana | Completed | Phase 2 | Metastatic Colorectal Cancer | Italy | 2017-12-07 |
| Docetaxel in Treating Patients With Refractory or Recurrent Advanced Gynecologic CancerNCT00287885 · Masonic Cancer Center, University of Minnesota | Completed | Phase 1 | Cervical Cancer, Endometrial Cancer, Fallopian Tube Cancer, and 5 more | Not listed | 2017-11-29 |
| Lower Dose Chemotherapy Given More Frequent With Avastin to Treat Advanced Non-Squamous Non-Small Cell Lung CancerNCT00655850 · University of Alabama at Birmingham | Completed | Phase 2 | Non-Small Cell Lung Cancer | United States | 2017-07-17 |
| Efficacy Study of Revlimid® and Low Dose Continuously Administered Melphalan to Treat High Risk MDSNCT00744536 · Sunnybrook Health Sciences Centre | Completed | Phase 2 | Myelodysplastic Syndromes, Leukemia, Myelomonocytic, Chronic, Angiogenesis | Canada | 2017-06-09 |
| Study of Everolimus and Low-dose Cyclophosphamide in Patients With Metastatic Renal Cell CancerNCT01462214 · Hans J. van der Vliet, MD, PhD | Completed | Phase 1, Phase 2 | Metastatic Renal Cell Cancer | Netherlands | 2017-05-10 |
| Phase II ABT-888 With CyclophosphamideNCT01306032 · National Cancer Institute (NCI) | Completed | Phase 2 | Ovarian Cancer, Primary Peritoneal Cancer, Serous Carcinoma Cancer, and 2 more | Canada, United States | 2017-04-26 |
| Clinical Study of Metronomic Oral Cyclophosphamide in Patients With Advanced SarcomasNCT01716689 · National Cancer Centre, Singapore | Completed | Phase 2 | Sarcoma | Singapore | 2017-03-29 |
| Phase I Trial of Oral Metronomic Topotecan and Oral Pazopanib to Treat Recurrent/Persistent Gynecologic TumorsNCT00800345 · Vector Oncology | Completed | Phase 1 | Gynecologic Tumors | United States | 2017-03-28 |
| A Phase Ⅱ Study of an All-Oral Combination of Low-dose Etoposide/Capecitabine in Patients With Metastatic Breast Cancer Previously Treated With Anthracyclines and/or TaxanesNCT01589159 · Tao OUYANG | Completed | Phase 2 | Metastatic Breast Cancer | China | 2017-02-27 |
| Low Dose Chemotherapy Versus Best Supportive Care in Progressive Pediatric MalignanciesNCT01858571 · All India Institute of Medical Sciences | Completed | Phase 3 | Malignant Childhood Neoplasm | India | 2017-01-25 |
| Combined Antiinflammatory and Angiostatic Therapy in Patients With Hormone-refractory Prostate CancerNCT00427999 · Novartis Pharmaceuticals | Completed | Phase 2 | Prostate Cancer | Germany | 2016-11-21 |
| Phase II Trial With Metronomic, Capecitabine Plus Oral Vinorelbine for Metastatic Breast CancerNCT01941771 · University of Aarhus | Completed | Phase 2 | Breast Cancer | Denmark | 2016-10-28 |
| ONCOS-102 (Previously CGTG-102) for Therapy of Advanced CancersNCT01598129 · Targovax Oy | Completed | Phase 1 | Malignant Solid Tumour | Finland | 2016-10-24 |
| Metronomic Vinorelbine and Bevacizumab in Patients With Non Small Cell Lung CancerNCT00755170 · Hellenic Oncology Research Group | Completed | Phase 2 | Non Small Cell Lung Cancer | Greece | 2016-10-04 |
| Relapse Myeloma; Cyclofosfamide; Bortezomib; MaintenanceNCT02467010 · University Medical Center Groningen | Completed | Phase 2 | Multiple Myeloma | Netherlands | 2015-06-09 |
| Avastin and Chemotherapy Followed by a KRAS Stratified Randomization to Maintenance Treatment for First Line Treatment of Metastatic Colorectal Cancer.NCT01229813 · Lund University Hospital | Completed | Phase 3 | Colorectal Cancer | Denmark, Sweden | 2015-04-13 |
| Etoposide, Cyclophosphamide, Thalidomide, Celecoxib, and Fenofibrate in Relapsed or Progressive CancerNCT00357500 · Dana-Farber Cancer Institute | Completed | Phase 2 | Central Nervous System Tumor, Pediatric, Leukemia, Lymphoma, and 3 more | United States | 2014-10-01 |
| Phase II Metronomic Dosing, Etoposide, Cyclophosphamide, D0 Prostate CancerNCT00176605 · Rutgers, The State University of New Jersey | Completed | Phase 2 | Prostate Cancer | United States | 2014-05-20 |
| Bevacizumab With or Without Cyclophosphamide and Methotrexate: A Pilot Study in Women With Operable Breast CancerNCT00121134 · Harold J. Burstein, MD, PhD | Completed | Not applicable | Breast Cancer | United States | 2013-12-24 |
| ZD6474 (Zactima) and Metronomic Chemotherapy in Advanced Breast CancerNCT00496665 · Dana-Farber Cancer Institute | Completed | Phase 1 | Metastatic Breast Cancer | United States | 2013-11-18 |
| Study of Combination of Metronomic Oral Vinorelbine and Sorafenib in Patients With Advanced Non-small Cell Lung CancerNCT00870532 · National Cancer Centre, Singapore | Completed | Phase 1 | Non-Small Cell Lung Cancer | Singapore | 2013-11-04 |
| Oral Topotecan to Treat Recurrent or Persistent Solid TumorsNCT00382733 · Accelerated Community Oncology Research Network | Completed | Phase 1, Phase 2 | Tumors | United States | 2013-07-22 |
| Bevacizumab in Combination With Metronomic Temozolomide for Recurrent Malignant GliomaNCT00501891 · Duke University | Completed | Phase 2 | Glioblastoma Multiforme | United States | 2013-05-27 |
| A Phase I Clinical Trial of Autologous Dendritic Cell Vaccine for Recurrent Ovarian or Primary Peritoneal CancerNCT00683241 · Abramson Cancer Center at Penn Medicine | Completed | Phase 1 | Ovarian Cancer, Peritoneal Cancer | United States | 2013-02-26 |
| Study of Oral Vinorelbine and Erlotinib in Non-Small Cell Lung CancerNCT00702182 · National Cancer Centre, Singapore | Completed | Phase 1 | Non-Small Cell Lung Cancer | Singapore | 2012-10-19 |
| Adjuvant Therapy for High-Risk Breast Cancer With Wkly Adriamycin & Oral Cytoxan With G-CSF for 12 Wks; Wkly Taxol x 12NCT00194753 · University of Washington | Completed | Phase 2 | Breast Neoplasm | United States | 2012-09-13 |
| Cisplatin, Etoposide, and Cyclophosphamide in Treating Patients With Extensive-Stage Small Cell Lung CancerNCT00083161 · Gundersen Lutheran Health System | Completed | Phase 2 | Lung Cancer | United States | 2012-09-05 |
| A Phase II Study of Pegylated Interferon Alfa 2b (PEG-Intron(Trademark)) in Children With Diffuse Pontine GliomasNCT00036569 · National Cancer Institute (NCI) | Completed | Phase 2 | Diffuse Intrinsic Pontine Glioma | United States | 2012-02-13 |
| Combination of Continuous Low Doses of Vinorelbine, Cyclophosphamide and Interferon Alpha 2b (" Metronomic Chemotherapy ") for Antiangiogenic and Antivascular Effect. Trial With Pharmacodynamic Study in Adult Advanced NeoplasmNCT00908869 · Institut Paoli-Calmettes | Completed | Phase 1 | Advanced Neoplasm | France | 2012-01-30 |
| UFUR Plus Thalidomide for Advanced Hepatocellular CarcinomaNCT00519688 · National Taiwan University Hospital | Completed | Phase 2 | Hepatocellular Carcinoma | Taiwan | 2011-10-17 |
| 5FU and Octreotide Long-acting Release (LAR) for Neuroendocrine TumorsNCT00953394 · University of Turin, Italy | Completed | Phase 2 | Neuroendocrine Tumors | Italy | 2009-08-06 |
| Metronomic Oral Vinorelbine in Patients With Metastatic TumorsNCT00278070 · Hellenic Cooperative Oncology Group | Completed | Phase 2 | Breast Cancer, Non Small Cell Lung Cancer, Prostate Cancer | Greece | 2008-02-29 |
| Comparison of Oral Cyclophosphamide vs Doxorubicin in ≥65 Years Old Advanced or Metastatic Soft Tissue Sarcoma PatientsNCT04757337 · UNICANCER | Status unknown | Phase 3 | Advanced Soft-tissue Sarcoma, Metastatic Soft-tissue Sarcoma | France | 2025-03-25 |
| Disitamab Vedotin in Combination with Metronomic Chemotherapy in Advanced HER2-expressing Breast Cancer.NCT06857747 · QIAO LI | Status unknown | Not applicable | Breast Cancer | Not listed | 2025-03-04 |
| Phase I Trial: T4 Immunotherapy of Head and Neck CancerNCT01818323 · King's College London | Status unknown | Phase 1 | Head and Neck Cancer | United Kingdom | 2024-10-09 |
| GALLANT: Metronomic Gemcitabine, Doxorubicin, Docetaxel and Nivolumab for Advanced SarcomaNCT04535713 · Sarcoma Oncology Research Center, LLC | Status unknown | Phase 2 | Sarcoma | United States | 2024-07-05 |
| Metronomic Oral Vinorelbine Combination With Tislelizumab in EGFR/ALK-negative Advanced NSCLCNCT06260553 · Fujian Cancer Hospital | Status unknown | Phase 2 | EGFR/ ALK-negative Advanced NSCLC | China | 2024-02-15 |
| Efficacy and Safety of Metronomic Oral Vinorelbine Plus Anlotinib in HER2-negative Metastatic Breast Cancer PatientsNCT06015126 · Yan Xue | Status unknown | Not applicable | Breast Cancer | China | 2023-08-29 |
| Metronomic Oral Chemotherapy With Cyclophosphamide, Capecitabine and Vinorelbine in Metastatic Breast Cancer PatientsNCT04304352 · European Institute of Oncology | Status unknown | Phase 2 | Advanced Breast Cancer | Italy | 2023-06-28 |
| EPstein-barr Virus DNA Response to Systemic Therapy for Treatment Adaptation in High Risk NPC (EP-STAR)NCT04072107 · Sun Yat-sen University | Status unknown | Phase 2 | Nasopharyngeal Carcinoma | China | 2023-06-18 |
| Letrozole Plus Metronomic Capecitabine as First-line Treatment for Patients With Recurrent or Metastatic Breast CancerNCT04942899 · Assiut University | Status unknown | Phase 2 | Metastasis Breast | Not listed | 2023-03-01 |
| Oral Vinorelbine and Capecitabine in Advanced HER2-negative Breast CancerNCT05747326 · Cancer Institute and Hospital, Chinese Academy of Medical Sciences | Status unknown | Phase 2 | Breast Cancer | China | 2023-02-28 |
| Chidamide in Combination With Vincristine Metronomic Chemotherapy for Advanced Triple-negative Breast CancerNCT05747313 · Cancer Institute and Hospital, Chinese Academy of Medical Sciences | Status unknown | Phase 1, Phase 2 | Breast Cancer, Chemotherapy Effect | China | 2023-02-28 |
| Almonertinib Plus Metronomic Oral VinorelbineNCT05663177 · Fujian Cancer Hospital | Status unknown | Not stated | EGFR, NSCLC, Third-generation TKI | Not listed | 2022-12-23 |
| Tucidinostat Combined With Metronomic Capecitabine and Endocrine Therapy for Advanced HR-positive, HER2-negative Breast Cancer After CDK4/6 Inhibitor.NCT05411380 · wang shusen | Status unknown | Phase 2 | Breast Cancer | China | 2022-11-04 |
| Tucidinostat and Metronomic Capecitabine for Metastatic Triple-negative Breast Cancer:a Multicenter,Open-label, Randomized Controlled, Phase II Clinical TrialNCT05390476 · wang shusen | Status unknown | Phase 2 | Triple Negative Breast Cancer | China | 2022-11-04 |
| Vinorelbine Metronomic Chemotherapy Combined With Hypofractionated Radiotherapy, PD-1/PD-L1 Sequential GM-CSF and IL-2 for Treatment of Advanced Refractory Non-small Cell Lung Cancer and Breast Cancer(PRaG 6.0)NCT05603013 · Second Affiliated Hospital of Soochow University | Status unknown | Phase 2 | Carcinoma, Non-Small-Cell Lung, Carcinoma Breast | China | 2022-11-02 |
| Metronomic PLD in Patients With Primary Endocrine Resistant ABCNCT03071926 · Fudan University | Status unknown | Phase 2 | Advanced Breast Cancer | China | 2022-04-20 |
| Immunotherapy and Chemotherapy in Unresectable Recurrent Loco-regionally Advanced Nasopharyngeal CarcinomaNCT04921995 · Fudan University | Status unknown | Phase 2 | Recurrent Nasopharyngeal Carcinoma, Unresectable Nasopharyngeal Carcinoma, Chemotherapy Effect, and 2 more | China | 2022-04-04 |
| Nivolumab After Induction Treatment in Triple-negative Breast Cancer (TNBC) PatientsNCT02499367 · The Netherlands Cancer Institute | Status unknown | Phase 2 | Breast Cancer | Netherlands | 2022-03-22 |
| Single-agent Capecitabine as Metronomic Chemotherapy in LAHNSCC (CMHN)NCT05044117 · Sun Yat-sen University | Status unknown | Phase 3 | Head and Neck Squamous Cell Carcinoma | China | 2022-03-03 |
| Safety and Efficacy of Toripalimab in HER2- Metastatic Breast Cancer Patients Treated With Metronomic VinorelbineNCT04389073 · Cancer Institute and Hospital, Chinese Academy of Medical Sciences | Status unknown | Phase 2 | Metastatic Breast Cancer | China | 2022-02-25 |
| A Study of Metronomic CP and JX-594 in Patients With Advanced Breast Cancer and Advanced Soft-tissue Sarcoma (METROmaJX)NCT02630368 · Institut Bergonié | Status unknown | Phase 1, Phase 2 | Solid Tumors, Soft-tissue Sarcoma, Breast Cancer | France | 2022-02-02 |
| Combination of Metronomic Capecitabine With Camrelizumab for Treatment of Refractory Solid Tumor Trial (Cohort 3)NCT04932187 · Ruijin Hospital | Status unknown | Phase 1 | Hepatobiliary, Pancreatic and Other Gastrointestinal Carcinoma (Non-stomach, Non-esophagi) | China | 2021-09-17 |
| Inetetamab Plus Cyclophosphamide Metronomic Chemotherapy Plus Aromatase Inhibitor in Metastatic HER2+/HR+ Breast CancerNCT04941885 · Sun Yat-sen University | Status unknown | Phase 2 | Breast Cancer | China | 2021-07-02 |
| Metronomic Chemotherapy With Capecitabine for Pancreatic CancerNCT03959150 · Ruijin Hospital | Status unknown | Phase 2, Phase 3 | Pancreatic Cancer | China | 2021-04-30 |
| Combination of Metronomic Capecitabine With Camrelizumab for Treatment of Refractory Solid Tumor Trial (Cohort 1)NCT04508686 · Ruijin Hospital | Status unknown | Phase 1 | Advanced Cervical Cancer | China | 2021-01-29 |
| ESR1 Mutations in Asian ER+ Metastatic Breast Cancer on Hormonal Therapy-based TreatmentsNCT04212702 · National Taiwan University Hospital | Status unknown | Not stated | Metastatic Breast Cancer | Taiwan | 2021-01-12 |
| Letrozole and Metronomic Capecitabine in ER-positive HER2 Negative Advanced Breast Cancer (B-001 Study)NCT04571437 · Cairo University | Status unknown | Phase 2 | Breast Cancer, Estrogen Receptor-positive Breast Cancer, Metastatic Breast Cancer | Egypt | 2020-10-01 |
| Combination of Metronomic Capecitabine With Camrelizumab for Treatment of Refractory Solid Tumor Trial (Cohort 2)NCT04510818 · Ruijin Hospital | Status unknown | Phase 1 | Head and Neck Cancer, Esophageal Squamous Cancer | China | 2020-08-14 |
| Capecitabine Maintenance Therapy Following Capecitabine Combined With Docetaxel in Treatment of mBCNCT01917279 · Binghe Xu | Status unknown | Phase 3 | Breast Neoplasms, Neoplasms by Site, Neoplasm Metastasis, and 2 more | China | 2020-07-23 |
| Targeting the Tumor Microenvironment in R/M SCCHNNCT03844763 · Gruppo Oncologico del Nord-Ovest | Status unknown | Phase 1, Phase 2 | Head and Neck Cancer | Italy | 2020-03-03 |
| Observational Study With Metronomic Oral Vinorelbine in Elderly Patients With Locally Advanced / Metastatic Non-small-cell Lung Cancer (NSCLC)NCT04208854 · International Group of Endovascular Oncology | Status unknown | Not stated | Locally Advanced/ Metastatic NSCLC | Italy | 2019-12-26 |
| Pyrotinib Combined With Capecitabine Metronomic Therapy in HER2-postitive Advanced Breast CancerNCT03923166 · Chinese Academy of Medical Sciences | Status unknown | Phase 2 | Breast Cancer | China | 2019-04-22 |
| MetronomIc CApecitabine and DOcetaxel as Second-line Chemotherapy for Advanced Gastric CancerNCT02007148 · International Group of Endovascular Oncology | Status unknown | Phase 2 | Gastric Adenocarcinoma, Gastroesophageal Junction Adenocarcinoma | Italy | 2019-02-27 |
| A Study to Evaluate the Efficacy and Safety of Oral Navelbine in Female Patients With HER2-Negative Metastatic Breast CancerNCT03854617 · Chinese Academy of Medical Sciences | Status unknown | Phase 2 | Human Epidermal Growth Factor 2 Negative Carcinoma of Breast | Not listed | 2019-02-26 |
| A Prospective Cohort to Study the Effect of Temozolomide on IDH Mutational Low Grade GliomasNCT02209428 · Huashan Hospital | Status unknown | Phase 2 | Astrocytoma, Oligodendroglioma, Oligoastrocytoma | China | 2019-02-21 |
| Endothelial Progenitor Cells in Cervical Cancer Patients Receiving ChemoradiationNCT00753610 · Mackay Memorial Hospital | Status unknown | Not stated | Cervical Cancer | Taiwan | 2018-08-17 |
| Letrozole Plus Low-Dose Metronomic Capecitabine Versus EC-T (Epirubicin/Cyclophosphamide Followed by Docetaxel) as Neoadjuvant Therapy for ER+/HER2-negative Breast CancerNCT03507465 · Guangdong Provincial People's Hospital | Status unknown | Phase 2, Phase 3 | Breast Cancer | China | 2018-04-25 |
| Phase Ib Study of Olaparib Plus Weekly Carboplatin and Paclitaxel in Relapsed Ovarian CancerNCT01650376 · Swedish Medical Center | Status unknown | Phase 1, Phase 2 | Stage III Ovarian Cancer, Stage IV Ovarian Cancer, Uterine Cancer | United States | 2018-03-23 |
| A Trial With Metronomic Low-dose Treosulfan, Pioglitazone and Clarithromycin Versus Standard Treatment in NSCLCNCT02852083 · University Hospital Regensburg | Status unknown | Phase 2 | Squamous Cell Lung Cancer, Non-Squamous Cell Lung Cancer, Non-Small Cell Lung Cancer | Germany | 2018-01-18 |
| Clinical Trial Evaluating Metronomic Chemotherapy in Patients With Metastatic OsteosarcomaNCT03063983 · Grupo de Apoio ao Adolescente e a Crianca com Cancer | Status unknown | Phase 2 | Osteosarcoma | Brazil | 2017-03-13 |
| Metronomic Versus Conventional Chemotherapy in as Maintenance Treatment in mCRCNCT02893540 · Ruijin Hospital | Status unknown | Phase 2, Phase 3 | Colorectal Cancer | China | 2016-09-16 |
| A Phase II Study of Tegafur-Uracil as Maintenance Chemotherapy in Patients With Stage II of Colon CancerNCT02887365 · National Taiwan University Hospital | Status unknown | Phase 4 | MSI-L/MSS, Stage II Colon Cancer | Taiwan | 2016-09-07 |
| Metronomic Chemotherapy in Advanced Gastric CancerNCT02855788 · Huashan Hospital | Status unknown | Phase 2 | Metastatic Gastric Cancer, Locally Advanced Gastric Cancer | China, United States | 2016-08-04 |
| Dose-Finding of Propranolol in Combination With Metronomic Fixed Oral Cyclophosphamide Based on Bivariate Efficacy-tolerability Outcome in Patients With Locally Advanced or Metastatic Angiosarcoma: A Collaborative and Innovative Phase I-II Sequential Trial by the French Sarcoma Group (GSF/GETO)NCT02732678 · Assistance Publique Hopitaux De Marseille | Status unknown | Phase 1, Phase 2 | Angiosarcoma | France | 2016-04-11 |
| Prospective Clinical Trial Evaluating Metronomic Chemotherapy in Patients With High-grade, Operable, Non-metastatic Osteosarcoma of the ExtremityNCT02273583 · Grupo de Apoio ao Adolescente e a Crianca com Cancer | Status unknown | Phase 2 | High Grade Osteosarcoma | Brazil | 2016-02-11 |
| Maintenance Treatment With Capecitabine Metronomic Chemotherapy and Chinese Traditional Medicine in Metastatic Colorectal CancerNCT02575378 · Ruijin Hospital | Status unknown | Phase 4 | Metastatic Colorectal Cancer | Not listed | 2015-10-14 |
| Metronomic Chemotherapy of Capecitabine After Standard Adjuvant Chemotherapy in Operable Triple Negative Breast CancerNCT02012634 · Xijing Hospital | Status unknown | Not stated | Breast Cancer, Capecitabine, Triple Negative Breast Cancer | China | 2014-11-13 |
| Cyclophosphamide, Radiation Therapy, and Poly ICLC in Treating Patients With Unresectable, Recurrent, Primary, or Metastatic Liver CancerNCT00553683 · Rutgers, The State University of New Jersey | Status unknown | Phase 1, Phase 2 | Breast Cancer, Colorectal Cancer, Gastric Cancer, and 5 more | United States | 2014-01-14 |
| Maintenance Treatment Versus Observation After Induction in Advanced Colorectal CarcinomaNCT00442637 · Dutch Colorectal Cancer Group | Status unknown | Phase 3 | Colorectal Cancer Metastatic | Netherlands | 2013-12-12 |
| Metronomic Cyclophosphamide in Combination With Standard Chemotherapy for Squamous Cell Lung CarcinomaNCT01947062 · Swami Rama Cancer Hospital and Research Institute | Status unknown | Phase 3 | Lung Cancer, Squamous Cell Carcinoma of the Lung, Locally Advanced and Metastatic Squamous Cell Carcinoma of the Lung | India | 2013-09-20 |
| Capecitabine Metronomic Chemotherapy Plus Aromatase Inhibitor for Postmenopausal Hormone Receptor Positive Breast CancerNCT01924078 · Fudan University | Status unknown | Phase 2 | Breast Cancer | China | 2013-08-16 |
| Trofosfamide Versus Adriamycin in Elderly Patients With Soft Tissue Sarcoma (STS)NCT00204568 · University Hospital Schleswig-Holstein | Status unknown | Phase 2 | Sarcoma, Soft Tissue | Germany | 2013-01-08 |
| Phase I and Consecutive Phase II, Two-arm, Randomized Multi-center Trial in Patients With Advanced MelanomaNCT01614301 · University of Regensburg | Status unknown | Phase 1, Phase 2 | Advanced Melanoma | Germany | 2012-06-07 |
| Low Dose Chemotherapy With Aspirin in Patients With Breast Cancer After Neoadjuvant ChemotherapyNCT01612247 · University of Vermont | Status unknown | Not applicable | Breast Cancer | United States | 2012-06-05 |
| Third-line Therapy of Multiple Myeloma a Prospective Phase I /II TrialNCT01010243 · University of Regensburg | Status unknown | Phase 1, Phase 2 | Multiple Myeloma | Germany | 2012-05-30 |
| Cisplatin, Metronomic Low-Dose Interferon Alfa, Gemcitabine, and Fever-Range Whole-Body Hyperthermia in Treating Patients With Inoperable or Metastatic Pancreatic CancerNCT00082862 · The University of Texas Health Science Center, Houston | Status unknown | Phase 2 | Pancreatic Cancer | United States | 2012-02-13 |
| Docetaxel With or Without Metronomic Cyclophosphamide as First Line Chemotherapy in Metastatic Breast CancerNCT01526499 · Fudan University | Status unknown | Phase 2 | Breast Cancer | China | 2012-02-07 |
| Low Dose of Metronomic Cyclophosphamide and Capecitabine in Pretreated HER2-negative Metastatic Breast CancerNCT01526512 · Fudan University | Status unknown | Phase 2 | Breast Cancer | China | 2012-02-07 |
| Metronomic Chemotherapy With Tegafur/Uracil for Head and Neck Squamous Cell CarcinomaNCT00855881 · Mackay Memorial Hospital | Status unknown | Phase 2 | Head and Neck Cancer | Taiwan | 2011-07-26 |
| Metronomic Temozolamide in Patients With Recurrent GlioblastomaNCT01308632 · Grupo Español de Investigación en Neurooncología | Status unknown | Phase 2, Phase 3 | Glioblastoma | Not listed | 2011-03-04 |
| Hyperthermia/Thermal Therapy With Chemotherapy to Treat Inoperable or Metastatic TumorsNCT00178698 · The University of Texas Health Science Center, Houston | Status unknown | Phase 2 | Neuroendocrine Cancer, Small Cell Lung Cancer, Non-Small Cell Lung Cancer, and 1 more | United States | 2011-03-03 |
| Hyperthermia With Chemotherapy for Locally Advanced or Metastatic Pancreas CancerNCT00178763 · The University of Texas Health Science Center, Houston | Status unknown | Phase 2 | Pancreatic Neoplasms | United States | 2011-03-03 |
| Bevacizumab Plus Somatostatin Analogue and Metronomic Capecitabine in Patients With Advanced Neuroendocrine TumorsNCT01203306 · University of Turin, Italy | Status unknown | Phase 2 | Neuroendocrine Carcinomas | Italy | 2010-09-16 |
| Letrozole Plus Oral Cyclophosphamide Plus/Minus Sorafenib as Primary Systemic Treatment in Breast Cancer PatientsNCT00954135 · University of Turin, Italy | Status unknown | Phase 2 | Breast Cancer | Italy | 2009-08-07 |
| Cyclophosphamide, Methotrexate, and Prednisolone With or Without Aromatase Inhibitor Therapy in Treating Postmenopausal Women With Metastatic Breast CancerNCT00687648 · National Cancer Centre, Singapore | Status unknown | Phase 2 | Breast Cancer | Singapore | 2009-06-17 |
| Thalidomide and Tegafur/Uracil(UFUR) in the Treatment of Advanced Colorectal CancerNCT00890188 · National Cheng-Kung University Hospital | Status unknown | Phase 2 | Colon Cancer | Taiwan | 2009-05-07 |
| Sorafenib Plus Paclitaxel in Adreno-Cortical-Cancer PatientsNCT00786110 · University of Turin, Italy | Status unknown | Phase 2 | Adrenocortical Carcinoma | Italy | 2009-02-24 |
| Safety Study of Oral Vinorelbine in Subjects With Non-Hematologic MalignanciesNCT00641160 · Metronome Therapeutics | Status unknown | Phase 1 | Nonhematologic Malignancies | United States | 2008-09-26 |
| Weekly Dosing of an Integrative Chemotherapy Combination to Treat Advanced Pancreatic CancerNCT00323583 · Seattle Cancer Treatment and Wellness Center | Status unknown | Phase 2 | Adenocarincoma of Pancreas, Stage III Pancreatic Cancer, Stage IVA Pancreatic Cancer, and 1 more | United States | 2007-05-08 |
| Trial of Neoadjuvant Docetaxel ± Metronomic Capecitabine/CTX Followed by FEC in Women With Operable Triple Negative Breast CancerNCT02897050 · Sun Yat-Sen Memorial Hospital of Sun Yat-Sen University | Suspended | Phase 2 | Breast Cancer | China | 2022-04-20 |
| Nivolumab in Combination With Metronomic Chemotherapy in Paediatrics Refractory / Relapsing Solid TumorsNCT03585465 · Centre Oscar Lambret | Terminated | Phase 1, Phase 2 | Childhood Solid Tumor | Belgium, France | 2026-09-17 |
| Zotiraciclib (TG02) Plus Dose-Dense or Metronomic Temozolomide Followed by Randomized Phase II Trial of Zotiraciclib (TG02) Plus Temozolomide Versus Temozolomide Alone in Adults With Recurrent Anaplastic Astrocytoma and GlioblastomaNCT02942264 · National Cancer Institute (NCI) | Terminated | Phase 1, Phase 2 | Brain Tumor, Astrocytoma, Astroglioma, and 2 more | United States | 2026-02-23 |
| QUILT-3.060: NANT Pancreatic Cancer Vaccine: Molecularly Informed Integrated Immunotherapy in Subjects With Pancreatic Cancer Who Have Progressed on or After Standard-of-care TherapyNCT03329248 · ImmunityBio, Inc. | Terminated | Phase 1, Phase 2 | Pancreatic Cancer | United States | 2024-12-12 |
| QUILT-3.080: NANT Pancreatic Cancer VaccineNCT03586869 · ImmunityBio, Inc. | Terminated | Phase 1, Phase 2 | Pancreatic Cancer | United States | 2024-08-27 |
| QUILT-3.067: NANT Triple Negative Breast Cancer (TNBC) Vaccine: Molecularly Informed Integrated Immunotherapy in Subjects With TNBC Who Have Progressed on or After Standard-of-care Therapy.NCT03387085 · ImmunityBio, Inc. | Terminated | Phase 1, Phase 2 | Triple Negative Breast Cancer | United States | 2024-08-09 |
| QUILT-3.090: NANT Squamous Cell Carcinoma (SCC) Vaccine: Subjects With SCC Who Have ProgressedNCT03387111 · ImmunityBio, Inc. | Terminated | Phase 1, Phase 2 | Squamous Cell Carcinoma | United States | 2024-08-05 |
| Low Dose Continuous Cyclophosphamide vs Standard Doxorubicin in Advanced Sarcoma Elderly PatientsNCT04656262 · Istituto Oncologico Veneto IRCCS | Terminated | Phase 3 | Soft Tissue Sarcoma Adult | Italy | 2024-07-08 |
| QUILT-3.039: NANT Pancreatic Cancer Vaccine: Combination Immunotherapy in Subjects With Pancreatic Cancer Who Have Progressed on or After Standard-of-care TherapyNCT03136406 · ImmunityBio, Inc. | Terminated | Phase 1, Phase 2 | Pancreatic Cancer | United States | 2024-06-11 |
| QUILT-3.070:Pancreatic Cancer Vaccine: Subjects With Pancreatic Cancer Who Have Progressed on or After Standard-of-care TherapyNCT03387098 · ImmunityBio, Inc. | Terminated | Phase 1, Phase 2 | Pancreatic Cancer | United States | 2024-05-22 |
| A 3 Arm Randomized Study on Health-related QoL of Elderly Patients With Advanced Soft Tissue SarcomaNCT04780464 · European Organisation for Research and Treatment of Cancer - EORTC | Terminated | Phase 3 | Advanced Soft-tissue Sarcoma | Cyprus, Jordan | 2024-02-22 |
| Temozolomide and Ascorbic Acid in Treating Patients With Recurrent High-Grade GliomaNCT02168270 · University of Nebraska | Terminated | Phase 1 | Anaplastic Astrocytoma, Anaplastic Oligodendroglioma, Anaplastic Oligoastrocytoma, and 2 more | United States | 2023-11-24 |
| T-DM1 Alone Versus T-DM1 and Metronomic Temozolomide in Secondary Prevention of HER2-Positive Breast Cancer Brain Metastases Following Stereotactic RadiosurgeryNCT03190967 · National Cancer Institute (NCI) | Terminated | Phase 1, Phase 2 | Breast Cancer, Brain Metastasis, Brain Cancer | United States | 2023-10-11 |
| Capecitabine, Cyclophosphamide, Lapatinib Ditosylate, and Trastuzumab in Treating Patients With HER2-Positive Metastatic Breast CancerNCT01873833 · University of Southern California | Terminated | Phase 2 | HER2-positive Breast Cancer, Recurrent Breast Cancer, Stage IV Breast Cancer | United States | 2023-10-05 |
| Addition of Aromatase at the Navelbine in Pretreated Metastatic Breast Cancer.NCT02585388 · ARCAGY/ GINECO GROUP | Terminated | Phase 2 | Breast Cancer | France | 2023-09-06 |
| BrUOG 329 Onivyde & Metronomic Temozolomide in Recurrent GlioblastomaNCT03119064 · Brown University | Terminated | Phase 1, Phase 2 | Glioblastoma Multiforme, Glioblastoma, GBM | United States | 2022-12-13 |
| Adjuvant Tumor Lysate Vaccine and Iscomatrix With or Without Metronomic Oral Cyclophosphamide and Celecoxib in Patients With Malignancies Involving Lungs, Esophagus, Pleura, or MediastinumNCT02054104 · National Cancer Institute (NCI) | Terminated | Phase 1, Phase 2 | Thoracic Sarcomas, Thorasic Cancers, Cancers of Non-thoracic Origin With Metastases to the Lungs or Pleura, and 2 more | United States | 2022-01-26 |
| Bevacizumab, Metronomic Chemotherapy (CM), Diet and Exercise After Preoperative Chemotherapy for Breast CancerNCT00925652 · Dana-Farber Cancer Institute | Terminated | Phase 2 | Breast Cancer | United States | 2022-01-19 |
| Phase II Trial of Neoadjuvant Metronomic Chemotherapy in Triple-Negative Breast CancerNCT00542191 · Leo W. Jenkins Cancer Center | Terminated | Phase 2 | Breast Cancer | United States | 2021-05-26 |
| Biological-guided Metronomic Chemotherapy as Maintenance Strategy in Metastatic Colorectal CancerNCT03158610 · Ruijin Hospital | Terminated | Phase 2, Phase 3 | Colorectal Cancer | China | 2021-05-03 |
| Liposomal Doxorubicin Compared With Observation or Cyclophosphamide and Methotrexate in Treating Older Women Who Have Undergone Surgery for Breast CancerNCT00296010 · ETOP IBCSG Partners Foundation | Terminated | Phase 3 | Breast Cancer | Australia, Belgium, Hungary, and 6 more | 2021-02-23 |
| A Open Study of Metronomic Oral Vinorelbine in Combination With Aromatase Inhibitors for the Treatment of Postmenopausal Women With Hormone Receptor Positive,HER2-negative, Advanced Breast Cancer Who Received no Prior Therapy for Advanced DiseaseNCT02730091 · Centre Hospitalier Universitaire de Besancon | Terminated | Phase 3 | Breast Cancer | France | 2021-02-01 |
| Phase 1b Safety Study of CMB305 in Patients With Locally Advanced, Relapsed, or Metastatic Cancer Expressing NY-ESO-1NCT02387125 · Immune Design, a subsidiary of Merck & Co., Inc. (Rahway, New Jersey USA) | Terminated | Phase 1 | Sarcoma, Melanoma, Non-small Cell Lung Cancer, and 1 more | United States | 2020-07-01 |
| Safety and Efficacy of Intra-Arterial and Intra-Tumoral Ad-p53 With Capecitabine (Xeloda) or Anti-PD-1 in Liver Metastases of Solid Tumors and Recurrent Head and Neck Squamous Cell CancerNCT02842125 · MultiVir, Inc. | Terminated | Phase 1, Phase 2 | Metastatic Solid Tumor Cancer, Recurrent Head and Neck Cancer | United States | 2020-06-02 |
| Oral Navelbine and Cisplatin Followed by Metronomic Oral Navelbine in Non-Small Cell Lung CancerNCT02985203 · Guangdong Association of Clinical Trials | Terminated | Phase 2 | Lung Neoplasm Malignant | China | 2020-03-12 |
| Tumor Cell Vaccine for Patients Undergoing Surgery for Sarcomas, Melanomas, Germ Cell Tumors, or Malignancies That Have Metastasized to the Lungs, Pleura, or MediastinumNCT01313429 · National Cancer Institute (NCI) | Terminated | Phase 1 | Sarcoma, Melanoma, Epithelial Malignancies, and 1 more | United States | 2020-03-03 |
| Pilot Study of Allogeneic Tumor Cell Vaccine With Metronomic Oral Cyclophosphamide and Celecoxib in Patients Undergoing Resection of Lung and Esophageal Cancers, Thymic Neoplasms, and Malignant Pleural MesotheliomasNCT01143545 · National Cancer Institute (NCI) | Terminated | Phase 1 | Lung Cancer, Esophageal Cancer, Malignant Pleural Mesothelioma, and 2 more | United States | 2020-03-03 |
| A Phase 2 Study of Viagenpumatucel-L (HS-110) in Patients With Non-Small Cell Lung CancerNCT02117024 · Heat Biologics | Terminated | Phase 2 | Non Small Cell Lung Cancer | United States | 2020-02-05 |
| Study of Pomalidomide, Oral Dexamethasone and Very Low-dose Cyclophosphamide in Patients With Refractory Multiple Myeloma Who Have Received Lenalidomide and BortezomibNCT04243109 · Maimónides Biomedical Research Institute of Córdoba | Terminated | Phase 2 | Multiple Myeloma | Spain | 2020-01-28 |
| Sunitinib, Cyclophosphamide, and Methotrexate in Treating Patients With Metastatic Breast CancerNCT00616122 · University of California, San Francisco | Terminated | Phase 1, Phase 2 | Breast Cancer | United States | 2020-01-13 |
| A Study of Intraventricular Liposomal Encapsulated Ara-C (DepoCyt) in Patients With Recurrent GlioblastomaNCT01044966 · Medical University of South Carolina | Terminated | Phase 1, Phase 2 | Glioblastoma Multiforme, Glioma, Astrocytoma, and 1 more | United States | 2019-02-12 |
| Metronomic Therapy in Patients With Metastatic MelanomaNCT01542255 · Dartmouth-Hitchcock Medical Center | Terminated | Phase 2 | Metastatic Melanoma | United States | 2019-01-15 |
| the Role of Two Different Metronomic Chemotherapy Regimens in Locally Advanced or Metastatic Triple Negative Breast Cancer Patients (TNBC) as Maintenance Therapy After First Line TreatmentNCT03358004 · Mario Negri Institute for Pharmacological Research | Terminated | Phase 2 | Triple Negative Breast Cancer | Italy, Portugal, Spain | 2018-10-05 |
| Tumor Cell Vaccines and ISCOMATRIX With Chemotherapy After Tumor RemovalNCT01341496 · National Cancer Institute (NCI) | Terminated | Phase 1 | Sarcoma, Melanoma, Epithelial Malignancies, and 1 more | United States | 2018-07-05 |
| Phase II Pilot Study Assessing Efficacy of a Cisplatin - Metronomic Cyclophosphamide Treatment in Patients With Metastatic Triple Negative Breast Cancer Resistant to Anthracyclines and TaxanesNCT01910870 · Centre Jean Perrin | Terminated | Phase 2 | Metastatic Breast Cancer | France | 2018-05-18 |
| Capecitabine With Digoxin for Metastatic Breast CancerNCT01887288 · Western Regional Medical Center | Terminated | Phase 2 | Metastatic Breast Cancer | United States | 2018-02-22 |
| Open-label, Multicenter, Randomized Phase II Trial of Treatment With Cisplatin and Pemetrexed or Cisplatin and Oral Vinorelbine in Chemotherapy Naïve Patients Affected by Stage IIIB-IV Non-Squamous Non-Small Cell Lung Cancer With High Thymidylate Synthase ExpressionNCT02919462 · Istituto Romagnolo per lo Studio dei Tumori Dino Amadori IRST S.r.l. IRCCS | Terminated | Phase 2 | Carcinoma, Non-Small-Cell Lung, Secondary, Advanced Stage IIIB, and 1 more | Italy | 2018-01-16 |
| Study of Low Dose Chemotherapy Plus Sorafenib as Initial Therapy for Patients With Advanced Non-Squamous Cell NSCLCNCT00801801 · Francisco Robert,MD | Terminated | Phase 2 | Non Squamous Cell Lung Cancer, Non Small Cell Lung Cancer | United States | 2017-05-17 |
| Lenalidomide, Sunitinib, and Cyclophosphamide in Treating Patients With Stage IV Eye MelanomaNCT00482911 · National Institutes of Health Clinical Center (CC) | Terminated | Phase 2 | Intraocular Melanoma, Malignant Conjunctival Neoplasm | United States | 2017-03-27 |
| Study With Pazopanib and Weekly Paclitaxel in Penile Carcinoma (PAZOPEN-SOGUG)NCT02279576 · Spanish Oncology Genito-Urinary Group | Terminated | Phase 2 | Penile Squamous Cell Carcinoma Stage IV | Spain | 2016-10-14 |
| Phase II Pilot Study Assessing Efficacy of a Cisplatin - Métronomic Cyclophosphamide Treatment in Patients With Stade IV Triple Negative Breast Cancer Secondary Resistant to Anthracyclines and TaxanesNCT01910844 · Centre Jean Perrin | Terminated | Phase 2 | Metastatic Breast Cancer | France | 2016-10-11 |
| A Study of AT-101 in Combination With Docetaxel in Squamous Cell Carcinoma Of The Head and NeckNCT01285635 · University of Michigan Rogel Cancer Center | Terminated | Phase 2 | Squamous Cell Carcinoma of the Head and Neck (SCCHN) | United States | 2016-03-31 |
| Vinorelbine Metronomic Plus Lapatinib for Overexpressing HER-2 Metastatic Breast CancerNCT00754702 · University Hospital of Crete | Terminated | Phase 2 | Breast Cancer | Greece | 2015-09-28 |
| Cilengitide and Metronomic Temozolomide for Relapsed or Refractory High Grade Gliomas or Diffuse Intrinsic Pontine Gliomas in Children and AdolescentsNCT01517776 · Martin-Luther-Universität Halle-Wittenberg | Terminated | Phase 2 | Gliomas | Germany | 2015-07-21 |
| Maintenance Metronomic Chemotherapy for Metastatic Colorectal CarcinomaNCT01668680 · HaEmek Medical Center, Israel | Terminated | Phase 2 | Colorectal Cancer Metastatic | Israel | 2015-07-08 |
| Low-Dose/Metronomic(LDM)Chemotherapy for Metastatic Breast CancerNCT01067989 · HaEmek Medical Center, Israel | Terminated | Phase 2 | Chemotherapy, Breast Cancer, Metastatic | Israel | 2015-07-08 |
| Maintenance Treatment for Ovarian Carcinoma in Remission by an Antiangiogenic Treatment StrategyNCT01175772 · HaEmek Medical Center, Israel | Terminated | Phase 2 | Ovarian Carcinoma | Israel | 2015-06-23 |
| Vinorelbine Metronomic Plus Bevacizumab as Salvage Therapy for Breast CancerNCT00694200 · Hellenic Oncology Research Group | Terminated | Phase 2 | Breast Cancer | Greece | 2015-05-29 |
| Randomized Phase II Trial of Anastrozole Plus Metronomic Tegafur-uracil as Neo-adjuvant Therapy in Postmenopausal Breast CancerNCT01262274 · Translational Research Center for Medical Innovation, Kobe, Hyogo, Japan | Terminated | Phase 2 | Breast Neoplasms | Japan | 2015-05-21 |
| Feasibility Study of Metronomic Chemotherapy for Locally Advanced Her2- Positive Breast Cancer (TraQ-Me 01)NCT01329640 · Instituto do Cancer do Estado de São Paulo | Terminated | Phase 2 | Locally Advanced HER2-positive Breast Cancer | Brazil | 2014-05-21 |
| Feasibility Study of Metronomic Chemotherapy for Locally Advanced HER2-Negative Breast CancerNCT01329627 · Instituto do Cancer do Estado de São Paulo | Terminated | Phase 2 | Locally Advanced HER2-negative Breast Cancer | Brazil | 2014-05-21 |
| Individualized Therapy Based of Tumoral mRNA Levels of ERCC1, RRM1 and BRCA1 in Advanced Non-Small-Cell Lung CancerNCT00705549 · Hellenic Oncology Research Group | Terminated | Phase 2 | Non-Small-Cell Lung Cancer | Greece | 2013-02-13 |
| Gliadel Wafer, Temozolomide and Radiation Therapy for Newly Diagnosed GBMNCT00548938 · Methodist Healthcare - Memphis | Terminated | Phase 2 | Glioblastoma Multiforme, High-Grade Glioma | United States | 2009-09-18 |
| QUILT-3.052: NANT Non-Hodgkin Lymphoma (NHL) Vaccine: Combination Immunotherapy in Subjects With Relapsed CD20-positive NHLNCT03169790 · ImmunityBio, Inc. | Withdrawn | Phase 1, Phase 2 | Non Hodgkin Lymphoma | Not listed | 2025-02-24 |
| QUILT-3.047: NANT Head and Neck Squamous Cell Carcinoma (HNSCC) Vaccine: Combination Immunotherapy in Subjects With HNSCC Who Have Progressed on or After Chemotherapy and PD-1/PD-L1 TherapyNCT03169764 · ImmunityBio, Inc. | Withdrawn | Phase 1, Phase 2 | Head and Neck Squamous Cell Carcinoma | Not listed | 2025-02-24 |
| QUILT-3.045: NANT Merkel Cell Carcinoma (MCC) Vaccine: Combination Immunotherapy in Subjects With MCC Who Have Progressed on or After PD-L1 TherapyNCT03167164 · ImmunityBio, Inc. | Withdrawn | Phase 1, Phase 2 | Merkel Cell Carcinoma | Not listed | 2025-02-21 |
| QUILT-3.051: NANT Ovarian Cancer Vaccine: Combination Immunotherapy in Subjects With Epithelial Ovarian Cancer Who Have Progressed on or After Standard-of-care (SoC) TherapyNCT03197584 · ImmunityBio, Inc. | Withdrawn | Phase 1, Phase 2 | Ovarian Cancer | Not listed | 2025-02-21 |
| QUILT-3.050: NANT Colorectal Cancer (CRC) Vaccine: Combination Immunotherapy in Subjects With Recurrent or Metastatic CRCNCT03169777 · ImmunityBio, Inc. | Withdrawn | Phase 1, Phase 2 | Colorectal Cancer | Not listed | 2025-02-21 |
| QUILT-3.044: NANT Non-small Cell Lung Cancer (NSCLC) Vaccine: Combination Immunotherapy in Subjects With NSCLC Who Have Progressed After Treatment With PD-1/PD-L1 InhibitorsNCT03169738 · ImmunityBio, Inc. | Withdrawn | Phase 1, Phase 2 | Non-small Cell Lung Cancer | Not listed | 2025-02-21 |
| QUILT-3.049: NANT Triple Negative Breast Cancer (TNBC) Vaccine: Combination Immunotherapy in Subjects With TNBC Who Have Progressed on or After Anthracycline-based ChemotherapyNCT03175666 · ImmunityBio, Inc. | Withdrawn | Phase 1, Phase 2 | Triple Negative Breast Cancer | Not listed | 2025-02-21 |
| QUILT-3.048: NANT Urothelial Cancer Vaccine: Combination Immunotherapy in Subjects With Urothelial Cancer Who Have Progressed on or After Chemotherapy and PD-1/PD-L1 TherapyNCT03197571 · ImmunityBio, Inc. | Withdrawn | Phase 1, Phase 2 | Urothelial Carcinoma | Not listed | 2025-02-21 |
| QUILT-3.046: NANT Melanoma Vaccine: Combination Immunotherapy in Subjects With Melanoma Who Have Progressed On or After Chemotherapy and PD-1/PD-L1 TherapyNCT03167177 · ImmunityBio, Inc. | Withdrawn | Phase 1, Phase 2 | Melanoma | Not listed | 2025-02-21 |
| QUILT-3.072: NANT Hepatocellular Carcinoma (HCC) VaccineNCT03563170 · ImmunityBio, Inc. | Withdrawn | Phase 1, Phase 2 | Hepatocellular Carcinoma Non-resectable, Hepatocellular Carcinoma Recurrent | United States | 2021-03-18 |
| DCVax-L Vaccination With CD3/CD28 Costimulated Autologous T-Cells for Recurrent Ovarian or Primary Peritoneal CancerNCT00603460 · University of Pennsylvania | Withdrawn | Phase 1, Phase 2 | Ovarian Cancer, Primary Peritoneal Cancer | United States | 2017-05-02 |
| Neoadjuvant Doxorubicin, Polyglutamate Paclitaxel, Capecitabine and Metronomic Chemotherapy in Breast CancerNCT01227408 · University of Southern California | Withdrawn | Phase 2 | Breast Cancer | United States | 2017-05-02 |
| Metronomic Docetaxel and Bevacizumab in Patients With Small Cell Lung CancerNCT00755157 · University Hospital of Crete | Withdrawn | Phase 2 | Small Cell Lung Cancer | Greece | 2015-10-07 |
| Bortezomib, Dexamethasone, and Cyclophosphamide in Treating Older Patients With Multiple MyelomaNCT02082405 · Case Comprehensive Cancer Center | Withdrawn | Phase 2 | Stage I Multiple Myeloma, Stage II Multiple Myeloma, Stage III Multiple Myeloma | Not listed | 2015-04-24 |
